Ulingo lwezonyango luqinisekisile ukuba iidosi eziphezulu zeSemaglutideinokunceda ngokukhuselekileyo nangempumelelo abantu abadala abatyebe kakhulu bafezekise ukunciphisa ubunzima. Oku kufunyanisiweyo kunika indlela entsha yonyango kwindyikityha yokutyeba ekhulayo yehlabathi.
Imvelaphi
I-Semaglutide yiI-GLP-1 i-receptor agonistyaphuhliswa ekuqaleni ukulawula i-glucose yegazi kuhlobo lwe-2 yeswekile. Kwiminyaka yakutshanje, abaphandi baye bafumanisa indima yayo ephawulekayoukulawulwa kokutya kunye nokulawula ubunzima. Ngokulinganisa isenzo se-GLP-1, i-Semaglutide iyanciphisa ukutya kwaye ilibazise ukukhupha isisu, ekugqibeleni iyancipha ukutya.
Idatha yeklinikhi
Itheyibhile engezantsi ishwankathela iziphumo zokulahleka kwesisindo ezibonwe ngamaxabiso ahlukeneyo e-Semaglutide kwizilingo zeklinikhi:
Idosi (mg/iveki) | UNciphiso lobunzima obuphakathi (%) | Abathathi-nxaxheba (n) |
---|---|---|
1.0 | 6% | 300 |
2.4 | 12% | 500 |
5.0 | 15% | 450 |
Uhlalutyo lwedatha
-
Isiphumo esixhomekeke kwithamo: Ukususela kwi-1mg ukuya kwi-5mg, ukulahleka kwesisindo kwanda ngokuqhubekayo.
-
Ibhalansi efanelekileyo: I-2.4mg / i-dose yeveki ibonise umphumo omkhulu wokulahleka kwesisindo (i-12%) kwaye yayineqela elikhulu labathathi-nxaxheba, elibonisa ukuba linokuba lilona xabiso eliqhelekileyo elicetyiswayo kwikliniki.
-
Ukhuseleko lwedosi ephezulu: I-dose ye-5mg ayizange ibangele iziganeko ezimbi kakhulu, ezibonisa ukuba iidosi eziphezulu zinokuthi ziphucule ngakumbi ukusebenza phantsi kweemeko zokhuseleko ezilawulwayo.
Itshathi yoMkhwa
Lo mfanekiso ulandelayo ubonisa impembelelo yeedosi ezahlukeneyo ze-Semaglutide ekunciphiseni ubunzima:
Ukuqukumbela
Njengeyeza elitsha lokunciphisa umzimba, i-Semaglutide ibonisa ngokucacileyoisiphumo sokunciphisa ubunzima esixhomekeke kwidosikulingo lwezonyango. Ngokunyuka kweedosi, izigulane ziye zafumana ukwehla kobunzima obuphakathi. Kwixesha elizayo, i-Semaglutide kulindeleke ukuba ibe lilitye lembombo kunyango lokukhuluphala, ukubonelela oogqirha ngeendlela ezininzi zonyango lomntu.
Ixesha lokuposa: Sep-17-2025